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Abstract The dystrophin-associated protein complex
(DPC) consisting of syntrophin, dystrobrevin, and dystro-
glycan isoforms is associated either with dystrophin or its
homolog utrophin. It is present not only in muscle cells,
but also in numerous tissues, including kidney, liver, and
brain. Using high-resolution immunofluorescence imaging
and Western blotting, we have investigated the effects of
utrophin and dystrophin gene deletion on the formation
and membrane anchoring of the DPC in kidney epithelial
cells, which co-express utrophin and low levels of the C-
terminal dystrophin isoform Dp71. We show that multiple,
molecularly distinct DPCs co-exist in the nephron; these
DPCs have a segment-specific distribution and are only
partially associated with utrophin in the basal membrane
of tubular epithelial cells. In utrophin-deficient mice, a
selective reduction of β2-syntrophin has been observed in
medullary tubular segments, whereas α1-syntrophin and
β1-syntrophin are retained, concomintant with an upre-
gulation of β-dystroglycan, β-dystrobrevin, and Dp71.
These findings suggest that β2-syntrophin is dependent on
utrophin for association with the DPC, and that loss of
utrophin is partially compensated by Dp71, allowing the
preservation of the DPC in kidney epithelial cells. This
hypothesis is confirmed by the almost complete loss of all
DPC proteins examined in mice lacking full-length
utrophin and all C-terminal dystrophin isoforms
(utrophin0/0/mdx3Cv). The DPC thus critically depends on
these proteins for assembly and/or membrane localization
in kidney epithelial cells.
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Neuromuscular junction . PT: Proximal tubules
Introduction
The dystrophin-associated protein complex (DPC) is a
multimeric membrane-spanning complex linked either to
dystrophin, a large X-linked cytoskeletal protein, or to its
autosomal homolog utrophin (Matsumura et al. 1992). In
skeletal muscle cells, the DPC is composed of α-
dystroglycan (an extracellular protein bound to laminin),
β-dystroglycan and sarcoglycans (spanning the mem-
brane), and dystrobrevins and syntrophins (located intra-
cellularly). Utrophin and dystrophin anchor this complex
to the cytoskeleton by binding to the intracellular tail of β-
dystroglycan and to actin filaments (Way et al. 1992;
Winder et al. 1995). Utrophin is selectively localized at the
neuromuscular junction (NMJ), whereas dystrophin is
present in the NMJ as well as along the inner face of the
surface membrane, the sarcolemma. The DPC seems to
contribute to the aggregation of acetylcholine receptors
(AChRs) at the NMJ and to enhance the structural stability
of the sarcolemma (Grady et al. 2000). Association of
signaling molecules, such as nitric oxide synthase, α5β1
integrin, and focal adhesion kinase, with the DPC also
suggests a role in signal transduction (Bredt 1999; Hillier
et al. 1999; Winder 2001). Disruption of the DPC by
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mutations in its main components results in severe muscle
dystrophies.
Dystrophin is expressed mainly in skeletal and cardiac
muscle and in the brain (Mehler 2000; Blake et al. 2002).
Short C-terminal dystrophin isoforms, ranging in size from
71 kDa to 260 kDa and lacking the actin-binding domain,
have a more widespread distribution (Ahn and Kunkel
1993; Austin et al. 1995; Sadoulet-Puccio and Kunkel
1996; Durbeej et al. 1997; Culligan et al. 1998; Lidov and
Kunkel 1998; Blake et al. 1999, 2002; Lumeng et al. 1999;
Chavez et al. 2000). Mice lacking dystrophin and all its C-
terminal isoforms including Dp71 (mdx3Cv) are viable,
allowing the role of these proteins in non-muscle tissues to
be investigated (Cox et al. 1993). Utrophin has a
ubiquitous expression pattern, with high levels in lung,
kidney, liver, nervous system, and blood vessels (Love et
al. 1993; Dixon et al. 1997; Grady et al. 1997a; Tinsley et
al. 1998; Rafael et al. 1999; Knuesel et al. 2000; Loh et al.
2000; Raats et al. 2000; Regele et al. 2000; Zuellig et al.
2000; Jimenez-Mallebrera et al. 2003; Haenggi et al.
2004). DPC proteins are molecularly heterogeneous, with
the isoforms of each protein being encoded by distinct
genes or being generated by alternative splicing or
differential promoter usage. In particular, dystrobrevins,
which are structurally homologous to dystrophin and
utrophin, are encoded by two separate genes, α-dystro-
brevin and β-dystrobrevin, the former being alternatively
spliced into five distinct isoforms (Blake et al. 1996;
Sadoulet-Puccio et al. 1996; Ambrose et al. 1997; Peters et
al. 1997b; Nawrotzki et al. 1998; Newey et al. 2001).
The syntrophin family likewise comprises several
isoforms in muscle encoded by separate genes (α1, β1,
β2) and two brain-specific genes (γ1 and γ2; Piluso et al.
2000; Blake et al. 2002). Whereas sarcoglycans are
muscle-specific (Blake et al. 2002), the dystrobrevin and
syntrophin isoforms exhibit a differential tissue distribu-
tion and are selectively associated with either dystrophin
or utrophin, suggesting the existence of several molecu-
larly and functionally distinct DPCs in non-muscle cells.
Analysis of mice with targeted mutations has revealed
the interdependence of the DPC with either utrophin or
dystrophin for assembly in muscle. For instance, mice
with dystroglycan-deficient skeletal muscles and mice
lacking α-syntrophin show severely reduced levels of
utrophin at the NMJ (Cote et al. 1999; Adams et al. 2000).
Conversely, α-dystrobrevins and the syntrophins disap-
pear from the muscle sarcolemma in the absence of
dystrophin (mdx mice) but are retained at the NMJ because
of their association with utrophin (Deconinck et al. 1997;
Grady et al. 1997a; Peters et al. 1997b). The phenotype of
utrophin0/0 mice has not been investigated in detail. These
mice are fertile and exhibit normal behavior and life span.
Their NMJ are functionally not altered, although they
contain fewer postsynaptic folds possibly because of
decreased AChR density (Deconinck et al. 1997; Grady et
al. 1997b).
Little is known, however, about the assembly, cellular
localization, and function of the DPC in non-muscle
tissues. The issue is further complicated because these
proteins are not readily detected in morphologically well-
preserved tissue, and the molecular composition of the
DPC may be cell-type specific (Loh et al. 2000).
The aim of the present study has been to investigate the
role of utrophin and the short dystrophin isoform Dp71 for
the assembly and subcellular localization of the DPC in
the various kidney nephron segments. Dp71 has been
reported to represent the main dystrophin isoform in
kidney (Lumeng et al. 1999; Loh et al. 2000, 2001). The
distribution of DPC proteins was analyzed by high-
resolution immunofluorescence staining in wild-type and
mutant mice (utrophin0/0 and utrophin0/0/mdx3Cv). Chang-
es in their expression levels have been assessed by
Western blotting experiments. The results reveal a distinct
molecular heterogeneity of the DPC in the different
segments of the nephron, identified with specific markers.
The DPC exhibits a polarized distribution in the basal
membrane of tubular epithelial cells in partial dependence
on utrophin expression. However, in the absence of
utrophin and all dystrophin isoforms in utrophin0/0/mdx3Cv
mice, the DPC is completely disrupted throughout the
nephron, demonstrating that the assembly and/or mem-
brane localization of the complex critically depends on
utrophin and Dp71.
Materials and methods
Animals
Utrophin0/0 mice were generated by crossing dystrophin–
utrophin double-mutants (mdx/utrophin0/0, generated on a
mixed 129-C57Bl/6 background; Grady et al. 1997a), with
wild-type C57Bl/6 mice (Institute of Animal Science,
University of Zurich) giving an F1 generation heterozy-
gous for utrophin (utrophin+/0; males) or utrophin and
dystrophin (mdx: utrophin+/0; females). Utrophin0/0 mice
were obtained by the crossbreeding of heterozygous or
homozygous mice. Utrophin0/0/mdx3Cv double-knockout
mice were generated by crossing utrophin0/0 mice with
mdx3Cv mice (Jackson Laboratories, Bar Harbor, Me.,
USA) giving an F1 generation heterozygous for utrophin
(utrophin+/0; females) and hemizygous for dystrophin
(mdx3Cv; males). Utrophin0/0/mdx3Cv double-knockout
mice were obtained by the crossbreeding of heterozygous
mice. For genotyping, DNA from tail biopsies was
analyzed by the polymerase chain reaction (PCR). The
double-knockout mice lived only 3–4 weeks postpartum.
They displayed severe muscle impairment and were
smaller by one third than wild-type mice. All animal
experiments were approved by the Cantonal Veterinary
Office of Zurich. Kidney tissue of α1-syntrophin0/0 mice
was obtained from Dr. M. Adams, Chapel Hill, N.C.,
USA.
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Immunoblotting
Kidney tissue from adult wild-type and utrophin0/0 mice
was homogenized in 1–2 volumes of ice-cold sucrose
buffer (0.32 M sucrose, 10 mM TRIS/HCl pH 7.4, 5 mM
EDTA, 0.02% NaN3, 0.2 mM phenylmethane sulfonyl-
fluoride). The homogenate was then made up to ten
volumes and centrifuged for 15 min at 1,000g. The
supernatant was aliquoted and stored at −80°C.
Crude kidney fractions were subjected to SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE) by using 4%
stacking and 10% gradient resolving gels. Proteins were
transferred onto nitrocellulose membranes (Bio Rad,
Reinach, Switzerland) in an electro-blotting apparatus
(Trans Blot, Bio Rad, Reinach, Switzerland) at 30 V
overnight, at 4°C. For immunodetection, the blots were
prepared as described by Knuesel et al. (2000). To
quantify changes in protein expression in utrophin0/0
mice, Western blots were performed with tissue from four
mutant and four wild-type animals, with actin as the
internal standard.
Immunofluorescence staining
Cryostat sections (12 μm) prepared from fresh-frozen
mouse kidney or striated muscle were mounted onto
gelatin-coated glass slides, air-dried at room temperature
for 30 s, and stored at −20°C. They were thawed at room
temperature, immersed in a Petri dish containing 50 ml
fixative solution composed of 0.5% paraformaldehyde,
5% Kryofix (Merck, Dietlikon, Switzerland) in 0.15 M
phosphate buffer, pH 7.4, irradiated in a microwave oven
(30 s at 480 W), and washed twice with phosphate-
buffered saline (PBS).
The sections were then incubated overnight at 4°C with
primary antibodies diluted in PBS containing 4% normal
goat serum (Table 1). Sections were washed extensively in
PBS and incubated for 30 min at room temperature with
secondary antibodies conjugated to Cy3 (1:500; Jackson
ImmunoResearch, West Grove, Pa., USA) or Alexa 488
(1:1,000; Molecular Probes, Eugene, Ore., USA). Sections
were washed again, air-dried, and cover-slipped with
buffered glycerol.
In control experiments, preadsorption of primary
antibodies with peptide antigen (1–10 μg/ml) resulted in
a dose-dependent loss of specific immunoreactivity. In
double-labeling experiments, omission of one of the
primary antibodies during overnight incubation led to
complete loss of signal with the corresponding secondary
antibodies, indicating the absence of cross-reactivity.
Data analysis
Sections were visualized by epifluorescence microscopy
(Zeiss; Jena, Germany), and images were recorded with a
digital camera (Orca, Hamamatsu City, Japan). For high
magnification imaging, sections were analyzed by laser
scanning confocal microscopy (LSM 510 Meta, Zeiss,
Jena, Germany) with sequential recording of double-
labeled sections to avoid bleed-through between channels.
Table 1 List of antibodies used. Double-immunofluorescence
staining experiments were performed with antibodies derived from
various species (aa amino acid, a.p. affinity-purified, AQP1/2
aquaporin 1/2, IMF immunofluorescence, MRP1/2 multidrug resis-
tant-associated protein 1/2, NKCC2 Na+–K+–Cl−-cotransporter 2,
WB Western blotting)
Protein Antigen/catalog number Species Dilution WB Dilution IMF Reference/source
Utrophin aa 1,754–2,089 Guinea pig 1:6,000 1:10,000 Knuesel et al. 2000
Rabbit – 1:10,000
β2-Syntrophin CSGSEDSGSPKHQTTKDR,
aa 206–223
Rabbit – 1:1,000 Present study
(a.p.) 4 μg/ml 4 μg/ml
Guinea pig 1:500 1:500
β1-Syntrophin CRLGGGSAEPLSSQSFSFHRDR,
aa 220–240
Rabbit – 1:2,000 Present study
(a.p.) 4 μg/ml 4 μg/ml
α1-Syntrophin CRQPSSPGPQPRNLSEA,
aa 191–206
Rabbit – 1:500 Present study
(a.p.) 4 μg/ml 4 μg/ml
Guinea pig – 1:2,000
Pan-syntrophin SYN1351E Mouse 1:10,000 – Froehner et al. (1987)
Pan-dystrobrevin βCT-FP Rabbit a.p. 1:1,000 1:1,000 Blake et al. (1998)
β-Dystroglycan NCL-b-DG Mouse 1:2,000 1:100 Novocastra, Newcastle upon Tyne, UK
Dystrophin (Dp71) Clone 6C5, aa 3,669–3,685 Mouse 1:25 1:100 Anawa trading, Wangen, Switzerland
AQP1 AB3065 Rabbit – 2 μg/ml Chemicon Int., Temecula, Calif., USA
AQP2 AB3274 Rabbit – 1:500 Chemicon Int.
MRP1 SLNKEDTSEEVVPVC, aa 243–256 Guinea pig – 1:2,000 J.-M. Fritschy, unpublished
MRP2 CEAIESVNHTEL, aa 1,530–1,541 Rabbit – 1:1,000 J.-M. Fritschy, unpublished
NKCC2 AB3562P Rabbit – 1:2,000 Chemicon Int.
Laminin AB2034 Rabbit – 1:2,000 Chemicon Int.
Actin A 2066 Rabbit – 1:5,000 Fluka Holding, Buchs, Switzerland
301
The digitized images were processed with the software
Imaris 3 (Bitplane, Zurich, Switzerland). Changes in
immunofluorescence intensity in tissue from utrophin0/0
mice were analyzed by semi-quantitative densitometry in
four animals per genotype by using the MCID M5
imaging system (Imaging Research, St-Catherine, ON,
Canada). Fluorescent latex beads with relative intensities
ranging from 0.1% to 100% were used for calibration
(Molecular Probes, Eugene, Ore., USA). For each animal,
images were taken under identical conditions at a magni-
fication of 0.07 μm/pixel with a 100× objective (numerical
aperture, 1.4). Immunopositive structures were outlined as
a region of interest for optical density measurement in
single confocal images for ten sections per animal. Data
were averaged per animal and statistically compared with
the Mann–Whitney test.
Results
Characterization of antibodies to syntrophin isoforms
Antibodies selectively recognizing α1-syntrophin, β1-
syntrophin, or β2-syntrophin (Table 1) were raised by
using peptide sequences derived from the first pleckstrin-
like domain of rat syntrophin genes (Peters et al. 1994) as
antigens. They were tested by immunofluorescence on rat
diaphragm (Fig. 1a) and mouse skeletal muscle sections
(Fig. 1b, c). β2-Syntrophin immunoreactivity (IR) was
most intense at the NMJ (Fig. 1a), whereas β1-syntrophin
IR and α1-syntrophin IR was found on the entire
sarcolemma (Fig. 1b, c) and at the NMJ (not shown), as
expected (Peters et al. 1997a; Adams et al. 2000). In
control experiments on kidney sections, specific immuno-
fluorescence staining was abolished upon preadsorption of
the antisera with their peptide antigen (Fig. 1d–i).
Molecular heterogeneity of the DPC in the nephron
A systematic comparison of the distribution of members of
the DPC in relation to specific markers of the main
segments of the tubular system revealed a unique pattern
for each of these proteins, with a striking regional
specificity (Figs. 2, 3, Table 2). Utrophin IR was
heterogeneous in the cortex, with glomeruli and isolated
tubular segments being most intensely stained (Fig. 2a).
These included the cortical thick ascending limbs, which
were double-labeled for the Na+–K+–Cl-cotransporter 2
(NKCC2; Payne et al. 1995; Fig. 2b), and connecting
Fig. 1 Specificity test of syn-
trophin antisera in adult striated
muscle a, b, c, and in kidney in
the absence d, f, h or presence e,
g, i of peptide antigen (5 μg/ml)
for competition. Intense β2-
syntrophin IR is seen at the
neuromuscular junction (NMJ)
in adult rat diaphragm (a),
whereas β1-syntrophin and α1-
syntrophin staining outlines the
entire sarcolemma in mouse
skeletal muscle (b, c). In kidney,
the distinct labeling of medul-
lary tubular epithelial cells, out-
lining individual tubules, was
abolished in preadsorption ex-
periments with β2-syntrophin
(d, e), β1-syntrophin (f, g), or
α1-syntrophin (h, i). Bars 20
μm (a), 40 μm (b, c), 30 μm (d–
i)
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tubules and collecting ducts, which were immunoreactive
for aquaporin 2 (AQP2; Nielsen et al. 1993a; Fig. 2c). In
contrast, utrophin IR was weak in the proximal tubules,
identified with aquaporin 1 (AQP1; Nielsen et al. 1993b;
Fig. 2d) or the multidrug resistant-associated protein 2
(MRP2; not shown). A different pattern was observed in
the medulla, where intense utrophin staining homoge-
neously labeled all tubular segments (Fig. 2e). With the
Fig. 2 Differential localization
of utrophin (green) in major
segments of the nephron identi-
fied with specific markers (red)
in double-immunofluorescence
experiments. Mouse kidney
cryosections were stained for
utrophin (utro), either alone (a,
e) or in combination with one of
the following markers: Na+/K+/
Cl−/cotransporter-2 (NKCC2; b,
f), aquaporin-2 (AQP2; c, g),
aquaporin-1 (AQP1; d, h), mul-
tidrug resistant-associated pro-
tein-1 (MRP1; i), and laminin
(k). Table 2 gives the distribu-
tion of these markers. The het-
erogeneous distribution of utro-
phin IR in the renal cortex (a) is
seen at low magnification, with
intense staining of glomeruli
(arrowheads) and isolated tu-
bules. Double-immunofluores-
cence images allow the identifi-
cation of the tubules of the
cortical thick ascending limbs
(b) and connecting tubules (c),
which are intensely stained for
utrophin (green). In contrast, the
proximal tubules (d) are only
weakly stained for utrophin. In
the medulla, utrophin IR is
homogeneously distributed (e),
with intense labeling of the thick
ascending limbs (f), collecting
ducts (g), and thin descending
limbs (h). Vascular bundles,
recognized by their intense
MRP1 staining appear devoid of
utrophin IR (i). Double-labeling
with laminin (k) illustrates the
close apposition of utrophin-
positive membranes (green)
with the basal lamina (red). Bars
200 μm (a, e, i), 30 μm (b–d),
(f–h), 5 μm (k)
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same markers as above (Table 2), utrophin IR was found
in medullary thick ascending limbs, which were positive
for NKCC2 (Fig. 2f), in the collecting ducts, which were
labeled with AQP2 (Fig. 2g), in the descending thin limb
of Henle’s loop, which was labeled with AQP1-IR (Fig.
2h), and in the ascending thin limbs, distal tubules, and
collecting ducts, which were all labeled with MRP1
(Cordon-Cardo et al. 1989; not shown). The only medul-
lary structures lacking utrophin IR were the vascular
bundles, which exhibited prominent MRP1 IR (Fig. 2i). At
the subcellular level, double-staining with laminin re-
vealed that the two markers were closely apposed but not
colocalized (Fig. 2k), suggesting that utrophin IR (green)
was restricted to the basal membrane of tubular cells.
The three syntrophin isoforms were colocalized par-
tially with utrophin, but each isoform had a unique
distribution pattern (Table 2). In the cortex, β2-syntrophin
IR was ubiquitous, being most intense in structures weakly
labeled with utrophin, such as the proximal tubules (Table
2). In contrast, the two markers were colocalized in the
medulla, outlining all tubules by a strong staining of the
basal membrane (Fig. 3a). Like utrophin IR, β2-
syntrophin IR was also absent from the medullary vascular
bundles. The β1-syntrophin antibody selectively labeled
all utrophin-positive tubules in the cortex (Table 2); in the
medulla, β1-syntrophin IR was heterogeneous, being
intense in descending thin limbs and collecting ducts,
but only weak in thick ascending limbs (Fig. 3b). Finally,
α1-syntrophin IR was heterogeneous in the cortex, being
restricted to connecting tubules and collecting ducts and
always colocalizing with utrophin (Table 2). In the
medulla, α1-syntrophin IR differed from β1-syntrophin
IR by weaker labeling of the thick ascending limbs and
thin descending limbs (Fig. 3c).
The dystrobrevin antibody revealed homogeneous
intense staining in the cortex and a heterogeneous pattern
in the medulla, with the thick ascending limbs being only
weakly labeled (Fig. 3d, Table 2). Although this antibody
recognized both α-dystrobrevin and β-dystrobrevin,
previous studies indicated that β-dystrobrevin was pre-
dominantly expressed in kidney epithelial cells (Kachins-
ky et al. 1999; Loh et al. 2000, 2001), suggesting that the
staining observed here mostly corresponded to this
isoform. Taken together, these observations that show
syntrophins and dystrobrevin were colocalized with
utrophin in the medulla. They could also occur in cortical
tubules devoid of utrophin staining (Table 2), where they
were presumably associated with dystrobrevin.
Finally, in line with the low abundance of β-
dystroglycan and Dp71 reported in kidney (Austin et al.
1995; Durbeej et al. 1997; Tokarz et al. 1998; Durbeej and
Campbell 1999; Lumeng et al. 1999; Loh et al. 2000),
Fig. 3 Subcellular distribution of DPC (red) proteins in medullary
tubules of wild-type mice (a–f) in relation to utrophin (green), as
seen by double-immunofluorescence staining. In the double-labeled
panels, colocalization appears yellow. Homogeneous utrophin IR
was detected in the basal membrane of medullary thick ascending
limbs and collecting ducts, and in small capillaries in the interstitial
tissue. Staining for most DPC proteins revealed a precise
colocalization with utrophin IR (yellow), as shown for β2-
syntrophin (a, β2-syn), β1-syntrophin (b, β1-syn), α1-syntrophin
(c, α1-syn), pan-dystrobrevin (d, DB), and β-dystroglycan (e, β-
DG). In contrast, Dp71 IR (f) was diffuse in the interstitial tissue but
was not detectable in tubules, as seen by the lack of colocalization
with utrophin (f). Tubules weakly labeled with β1-syntrophin, α1-
syntrophin, and pan-dystrobrevin were medullary thick ascending
limbs, whereas collecting ducts and descending thin limbs were
intensely labeled. Note that no dystrobrevin IR was present in the
interstitial tissue. Bar 20 μm
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immunofluorescence for these proteins appeared weak and
diffuse in the nephron (Fig. 3e, f, Table 2). Only glomeruli
and blood vessels were intensely stained. β-Dystroglycan
staining was moderate in the vascular bundles and isolated
capillaries but weaker in medullary tubules; it was
however colocalized with utrophin IR (Fig. 3e). Dp71
IR appeared as weak as β-dystroglycan staining (Fig. 3f).
However, at high resolution, Dp71 IR clearly outlined
interstitial capillaries but was not detectable in the basal
membrane of the thick ascending limbs and collecting
ducts. The absence of dystrophin was confirmed by the
lack of colocalization with utrophin (Fig. 3f). Control
experiments were performed in mdx3Cv mice, in which no
specific dystrophin IR was detected (not shown).
In the glomeruli, which stained intensively for both
utrophin and Dp71, the two proteins did not colocalize
(not shown). Utrophin IR was present in the Bowman’s
capsule and the intraglomerular convolutes, whereas Dp71
IR was absent from the capsule. The Dp71 antibody
stained most prominently in regions toward the macula
densa but also bound to intraglomerular structures, a result
different from that for utrophin IR. This distribution
suggested the presence of utrophin in capsular and
intraglomerular epithelial cells and corresponded to elec-
tron-microscopic identification of utrophin in a granular
podocyte-like staining pattern along the glomerular cap-
illary walls (Raats et al. 2000; Regele et al. 2000). On the
other hand, Dp71 seemed to localize to the mesangial and/
or endothelial cells, similarly to a particular Dp71 splice
variant, Dp71ΔC (Loh et al. 2000). This differential
distribution of utrophin and Dp71 corresponded to that
observed in the utrophin-positive nephron segments.
Glomeruli were not examined in further detail, because
specific markers for the various cell types in the glomer-
ulus were not identified, and because the secondary anti-
mouse IgGs, used to detect monoclonal antibodies,
produced a high background in these structures.
Alteration of the DPC in kidney of utrophin0/0 mice
The role of utrophin for the formation of the DPC in the
nephron was investigated by analyzing potential altera-
tions in the subcellular distribution of DPC proteins in
utrophin0/0 mice (Fig. 4a–h, Tables 3, 4). The analysis was
performed in the medulla, in which the distribution of
utrophin was the most homogeneous. Sections from wild-
type and mutant mice were processed in parallel under
identical conditions and with the same reagents to
minimize staining variability. In control experiments, no
utrophin staining could be detected in sections from
mutant mice, confirming the specificity of the antibody.
Table 2 Distribution of DPC proteins in relation to markers
(MRP1/2 multidrug resistant-associated protein 1/2, NKCC2 Na+/K
+/Cl-cotransporter 2) of the renal tubules (ATL ascending thin limbs,
CNT connecting tubules, CCT cortical collecting ducts, CTAL
cortical thick ascending limbs, DTL descending thin limbs, MCT
medullary collecting ducts, MTAL medullary thick ascending limbs,
PT proximal tubules) and vasculature (BV blood vessels) as obtained
by double-immunofluorescence staining. Signal intensities were
assessed by visual inspection and ranged from background (−) to the
most intense staining for each antibody (+++).
Marker Renal tubules Vasculature
PT DTL ATL MTAL/CTAL CNT CCT/MCT BV Vascular bundles
Aquaporin 1 +++ +++ − − − − + −
Aquaporin 2 − − − − ++ +++ − −
MRP1 − − +++ − − − +++ +++
MRP2 +++ − − − − − +++ −
NKCC2 − − − +++ − − − −
Utrophin + +++ +++ +++ +++ +++ +++ −
β2-Syntrophin +++ +++ +++ +++ +++ +++ +++ −
β1-Syntrophin − +++ + + +++ +++ +++ −
α1-Syntrophin + + + + + + +++ −
Dystrobrevin +++ ++ ++ + +++ +++ − −
β-Dystroglycan + + + + + + +++ ++
Dp71 − − − − − − +++ ++
Table 3 Alteration of DPC protein IR in utrophin0/0 mice:
comparison of immunofluorescence and Western blot experiments.
Quantification of immunohistochemical data and immunoblotting
experiments on four wild-type and four utrophin0/0 mice. Changes in
calibrated immunofluorescence intensity were assessed in medullary
tubular segments (thick ascending limbs and collecting ducts).
Immunoreactive bands in Western blots were measured by using a
diffuse density standard curve, and values were normalized to actin
levels on the same blots (NS not significant). α-Dystrobrevin and β-
dystrobrevin could be differentiated in Western blots by their
molecular size, but not in the immunofluorescence experiments
(pan-dystrobrevin antibody).
DPC proteins Immunofluorescence
(% of wild-type)
Western blot
(% of wild-type)
β2-Syntrophin 51±12.2* 77±7.6; NS
β1-Syntrophin 101±0.3; NS Not quantified
α1-Syntrophin 102±0.2; NS Not quantified
Pan-dystrobrevin 121±0.9* –
α-Dystrobrevin – 114±42.5; NS
β-Dystrobrevin – 101±10.3; NS
β-Dystroglycan 163±12.6* 60±15.7; NS
Dp71 352±31.4* 260±108*
*P<0.05; Mann–Whitney test
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β2-Syntrophin IR was markedly decreased in the
medulla of utrophin0/0 mice compared with that of the
wild-type (Fig. 4a, b). The remaining staining was still
localized along the basal membrane of the epithelium in
the absence of utrophin (Fig. 4b). This change was highly
specific, since β2-syntrophin IR remained unaltered in the
Fig. 4 Alterations of DPC pro-
tein staining were assessed by
using low-resolution confocal
images of the renal medulla of
wild-type (a, c, e, g), utrophin0/0
(b, d, f, h), and utrophin0/0/
mdx3Cv (i–m) mice. The images
illustrate the reduction of β2-
syntrophin IR in utrophin0/0
mice (a, b) in contrast to the
unaltered β1-syntrophin IR and
α1-syntrophin IR (c, d, and e, f,
respectively) and to the en-
hanced dystrobrevin staining,
which becomes almost homo-
geneous because of the in-
creased labeling of the thick
ascending limbs (g, h). In
utrophin0/0/mdx3Cv mice, the ef-
fects are much more pro-
nounced, and an almost com-
plete loss of staining is observed
for β2-syntrophin (i), β1-syn-
trophin (k), and dystrobrevin
(m). Note, however, that α1-
syntrophin IR is only partially
reduced in the collecting tubules
(l) in the double-mutant mice.
Bar 50 μm
Table 4 Alteration of DPC protein IR in utrophin0/0 (Utro0/0) and
utrophin0/0/mdx3Cv (Dko) mice (ne not expressed, CCT cortical
collecting ducts, MCT medullary collecting ducts, MTAL medullary
thick ascending thin limbs, PT proximal tubules). Signal intensities
of DPC proteins in specific renal segments were assessed by visual
inspection and ranged from not changed (=), to decreased IR (↓),
and to no detectable IR (↓↓) on the one hand, and to increased IR (↑)
and to strongly increased IR (↑↑) on the other.
Genotype Renal segments
PT CCT MTAL MCT
Utro0/0 Dko Utro0/0 Dko Utro0/0 Dko Utro0/0 Dko
β2-Syntrophin = ↓↓ = ↓↓ ↓↓ ↓↓ ↓↓ ↓↓
β1-Syntrophin = ↓↓ = ↓↓ = ↓↓ = ↓↓
α1-Syntrophin = ↓ = ↓ = ↓↓ = ↓
Dystrobrevin = ↓↓ = ↓↓ ↑ ↓↓ ↑ ↓↓
Dp71 = ne = ne ↑↑ ne ↑↑ ne
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cortex including the glomeruli (not shown), in particular in
the proximal tubules in which it was normally not
associated with utrophin. In striking contrast, no change
in staining intensity or distribution could be observed for
β1-syntrophin IR in mutant kidney compared with that of
the wild-type (Fig. 4c, d) in tubules of both the cortex and
medulla. The same observation was made for α1-
syntrophin IR, which was still present in the thick
ascending limbs of utrophin-deficient kidney (Fig. 4e, f).
These results indicated an obligatory association of β2-
syntrophin with utrophin in the membrane of medullary
tubular epithelial cells, whereas β1-syntrophin and α1-
syntrophin appeared independently of utrophin.
The absence of utrophin also affected β-dystrobrevin
staining, but in the opposite direction. Indeed, the
heterogeneous labeling seen in the medulla of wild-type
mice (Fig. 4g) was replaced by intense homogeneous IR in
all thick ascending limbs and collecting ducts (Fig. 4h).
This result suggested that the DPC was partially main-
tained in the absence of utrophin, possibly by a compen-
satory increase of β-dystrobrevin IR. When visualized at
high magnification, β-dystrobrevin staining clearly was
enhanced at the surface of tubules in the utrophin0/0 kidney
compared with that of the wild-type (Fig. 5a, b). The
increased β-dystrobrevin IR therefore was used in double-
labeling experiments to determine the localization of β-
dystroglycan and Dp71. The former was also increased in
the medulla of utrophin0/0 mice and was colocalized with
β-dystrobrevin (Fig. 5c). Even more striking was the
pronounced Dp71 IR in the basal membrane of the
collecting ducts and thick ascending limbs in utrophin-
deficient kidney; this IR was likewise colocalized with β-
dystrobrevin IR (Fig. 5d).
Changes in immunofluorescence staining between mu-
tant and wild-type medulla were quantified by densitom-
etry (Table 3). The measurements were confined to the
Fig. 5 High-resolution images
of wild-type (a) and utrophin0/0
(b–d) kidney demonstrating the
increased staining of dystrobre-
vin IR in the basal membrane of
the thick ascending tubules (a,
b). Selective colocalization of
β-dystroglycan (c; red) and
Dp71 (d; red) with dystrobrevin
(green) is indicated in the mu-
tant by yellow resulting from the
overlay. Bar 5 μm
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basal membrane of medullary thick ascending limbs and
collecting ducts. In wild-type, the cell surface was
localized by using utrophin as the reference; in mutants,
dystrobrevin IR was used. This analysis revealed an
almost 50% decrease in β2-syntrophin IR in mutant
kidney and confirmed that β1-syntrophin and α1-
syntrophin staining remained unaltered. Dystrobrevin–
dystroglycan IR and β-dystroglycan IR were increased by
more than 20% and 50%, respectively, in mutant mice,
whereas Dp71 IR had more than tripled (Table 3). Taken
together, these results indicated that the DPC normally
associated with utrophin in medullary tubules had been
replaced by a different complex containing β-dystrogly-
can, Dp71, dystrobrevin, β1-syntrophin, and α1-syntro-
phin.
Specific upregulation of Dp71 protein expression in
utrophin0/0 mice
The pronounced alterations in immunofluorescence stain-
ing observed in utrophin0/0 mice raised the question as to
whether they reflected a change in protein expression or in
subcellular localization. Crude kidney extracts prepared
from wild-type and utrophin-deficient mice were analyzed
by Western blotting (Fig. 6, Table 3). We focused on β2-
syntrophin, dystrobrevin, β-dystroglycan, and Dp71,
which exhibited differential alterations in immunofluores-
cence staining. In these experiments, we could discrimi-
nate between α1-dystrobrevin and β-dystrobrevin iso-
forms based on their molecular weight and could show
that β-dystrobrevin was more abundant than the α1
isoform (Fig. 6, left panel), confirming previous studies
(Blake et al. 1999; Loh et al. 2000).
The increased dystrobrevin and β-dystroglycan immu-
nofluorescence in sections from utrophin0/0 kidney could
not be replicated in the Western blots (Fig. 6, right panel).
Conversely, in spite of the profound reduction of β2-
syntrophin immunofluorescence, no significant decrease
was seen in Western blots (Fig. 6). However, a strong
increase in Dp71 protein levels was observed (Fig. 6,
Table 3). A compensatory upregulation of this protein
might therefore play a crucial role for the maintenance of
the DPC in the absence of utrophin.
Disruption of the DPC in kidney of utrophin0/0/mdx3Cv
mice
To verify this hypothesis, we investigated the kidney of
double-mutant mice (utrophin0/0/mdx3Cv) lacking both
utrophin and all C-terminal dystrophin isoforms (Fig. 4i–
m, Table 4). Most strikingly, the staining of the DPC
proteins investigated was largely abolished in tubular
epithelial cells and in glomeruli, suggesting that the DPC
was not formed in the nephron in the absence of utrophin
and Dp71. These results, as illustrated for the medulla
(Fig. 4i–m), also provided indirect evidence for the
specificity of our antibodies. Unexpectedly, however,
α1-syntrophin IR was only partially decreased in medul-
lary collecting ducts (Fig. 4l), raising the question as to
whether this protein existed alone or whether this staining
was an artifact.
Therefore, immunofluorescence experiments were per-
formed in α1-syntrophin0/0 kidney (Adams et al. 2000).
The localization and intensity of the β2-syntrophin IR and
β1-syntrophin IR appeared normal in these mice, in both
cortex and medulla (Fig. 7). However, the α1-syntrophin
staining in the medulla disappeared only from the thick
ascending limbs and was partially retained in the
collecting ducts (Fig. 7m), as also seen in utrophin0/0/
mdx3Cv mice (Fig. 4l). This result indicated that the α1-
syntrophin antibody was not totally specific in this
segment of the nephron. Therefore, α1-syntrophin, like
the other members of the DPC, did not remain in the cell
membrane of tubular epithelial cells in the absence of
utrophin and dystrophin. Caution had therefore to be
applied to the interpretation of the immunofluorescence
experiments, since the non-specific staining in collecting
ducts produced by the α1-syntrophin antibody had not
been revealed by the preadsorption experiments (Fig. 1i).
Fig. 6 Semi-quantitative Western blotting of crude kidney extracts
from wild-type and utrophin0/0 mice. Lanes were loaded with 5, 10,
and 20 μg protein (left to right) and probed with the antibodies
indicated far right. α-Dystrobrevin-1 (α-DB-1; 78 kDa) and β-
dystrobrevin (β-DB; 63 kDa) were both detected with the pan-
dystrobrevin antibody (see Table 1). All lanes were also labeled with
antibodies to actin as a control for protein loading and blotting
efficiency. No difference in staining intensity was observed between
genotypes for β2-syntrophin (β2-syn), β-dystroglycan (β-DG), α-
dystrobrevin-1 (α-DB-1) and β-dystrobrevin (β-DB). In contrast,
staining for Dp71 was markedly increased in the absence of
utrophin. Note the low abundance of α-dystrobrevin compared with
β-dystrobrevin in both genotypes. The results of the quantification
are given in Table 3.
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Discussion
The present study provides morphological evidence for the
existence of multiple, molecularly distinct DPCs in kidney
tubular epithelial cells. This heterogeneity arises from the
differential segment-specific distribution of utrophin,
dystrobrevin, α1-syntrophin, and β1-syntrophin, whereas
β2-syntrophin is present throughout the nephron, together
with low levels of β-dystroglycan. In the kidney of
utrophin-deficient mice, a profound reorganization takes
place, with β2-syntrophin disappearing from the medul-
lary segments, and Dp71 being upregulated and associated
with increased levels of β-dystrobrevin and β-dystrogly-
can. This compensatory mechanism is lost in mice that
lack both utrophin and C-terminal dystrophin isoforms and
in which the DPC is disrupted throughout the nephron.
These findings reveal a complex interdependence
among members of the DPC for assembly and cell-
membrane expression. β2-Syntrophin is dependent on
utrophin in the medulla but not in the cortex, whereas α1-
syntrophin, β1-syntrophin, and dystrobrevin require Dp71
for cell membrane expression. In spite of its homology
with dystrophin and utrophin, dystrobrevin cannot form a
DPC in kidney tubular epithelial cells in the absence of
these partners.
Organization of the DPC in the nephron
We have used segment-specific markers to investigate the
organization of the DPC in the nephron and have carried
out immunofluorescence experiments on sections weakly
fixed by microwave irradiation to minimize loss of
antigenicity following fixation (Fritschy et al. 1998).
This procedure results in a strong specific immunofluo-
rescence signal, while allowing satisfactory morphological
preservation. In contrast, preliminary experiments in
perfusion-fixed tissue have revealed only a low signal-
to-noise ratio for all DPC proteins tested. The issue of
antibody specificity and sensitivity has been a major
concern in this study. The almost complete loss of staining
seen for all DPC proteins analyzed in double-mutant mice
provides an indirect validation of the staining specificity.
Although the α1-syntrophin antibody apparently recog-
nizes an additional protein in collecting tubules, this
marker is not associated with the cell membrane and does
not invalidate our conclusions. With regard to the
dystrobrevin isoforms, our results confirm the predomi-
nance of β-dystrobrevin over α-dystrobrevins (Fig. 6).
Since α-dystrobrevin-1 is present mainly in glomeruli and
blood vessels (Loh et al. 2000, 2001), and since α-
dystrobrevin-2 is not expressed in kidney (Blake et al.
1996; Loh et al. 2001), the present description of
dystrobrevin IR therefore mainly corresponds to β-
dystrobrevin.
Our approach has allowed the unambiguous identifica-
tion of six distinct segments (proximal tubule, descending
thin limb, ascending thin limb, thick ascending limb,
connecting tubules, and collecting duct) in which the
major DPC proteins have been detected (Table 2). The
glomerulus has not been analyzed in detail, because the
various glomerular cell types could not be identified by
Fig. 7 Specificity test of syn-
trophin antisera in renal cortex
and medulla of wild-type (a, c,
e, g, i, l) and α1-syntrophin-
knockout (α1-syntrophin0/0)
mouse kidney (b, d, f, h, k, m).
β2-Syntrophin (a–d), β1-syn-
trophin (e–h), and α1-syntro-
phin (i–m). β2-Syntrophin
staining in the cortex (a, b) and
medulla 8c, d) was identical in
both genotypes. The same ob-
servation was made for β1-
syntrophin staining (e–h). Un-
expectedly, some α1-syntrophin
IR was retained in cortical (i–k)
and medullary (l, m) collecting
ducts, whereas the labeling of
the remaining structures, in par-
ticular the medullary thick as-
cending limbs was abolished.
The antiserum therefore recog-
nized another protein selectively
in collecting ducts, in addition
to α1-syntrophin. Bar 40 μm
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immunofluorescence. In all the staining combinations
analyzed in tubular epithelial cells, DPC proteins are
precisely colocalized with each other, suggesting that they
are part of the same complex. The DPC is probably
anchored in the basal membrane, as evidenced by the close
apposition of utrophin and laminin. Thus, laminin
probably plays an important role in determining the
localization of the DPC.
A major finding of this study is that the molecular
composition of the DPC is different in each of these six
segments of the nephron, because of the differential
expression of utrophin, α1-syntrophin, β1-syntrophin, β2-
syntrophin, and dystrobrevin. The distal parts of the
nephron exhibit strong staining for utrophin, dystrobrevin,
and the three syntrophin isoforms. The thick ascending
limbs contain mainly utrophin and β2-syntrophin. The
proximal tubules mainly contain dystrobrevin together
with β2-syntrophin and only little utrophin. The hetero-
geneity in the expression of the syntrophin isoforms and
their differential pattern of coexpression with each other
and with dystrobrevin suggest that the molecularly distinct
DPCs fulfill distinct functions in the various segments of
the nephron.
Finally, the present results confirm that Dp71 is
expressed at low protein levels in normal kidney (Lumeng
et al. 1999; Loh et al. 2000). The antibody used is directed
against the last 17 amino acid residues at the C-terminal of
dystrophin and hence recognizes all dystrophin isoforms
containing exon 78 (Austin et al. 1995). In addition to
Dp71, a larger C-terminal dystrophin isoform, Dp140, has
been localized to the basal surface of the tubule epithelium
(Lidov and Kunkel 1998). Both Dp71 and Dp140 are
reported to occur in kidney in splice variants missing exon
78 (Austin et al. 1995; Lidov and Kunkel 1997; Loh et al.
2000). In both cases, the most C-terminal residues are
different in the splice variants and are not recognized by
the antibody used here. The splice variant of Dp71, called
Dp71ΔC, has been reported to be abundant in the cortex,
notably in the proximal tubules, connecting tubules, and
collecting ducts (Loh et al. 2000). No information is
available concerning Henle’s loop and the thick ascending
tubules. Dp71ΔC could thus play a role in the assembly of
the DPC in those segments of the nephron in which
utrophin is scarce.
Alterations of the DPC in utrophin-deficient mice
The analysis of utrophin0/0 mice has yielded three distinct
results. (1) In the major parts of the nephron, including the
proximal tubules, loop of Henle, and collecting ducts, the
DPC is not affected by the loss of utrophin. This result
could be explained either by the presence of Dp71ΔC or
by the upregulation of Dp71. (2) In the thick ascending
limb of the medullary tubules, the absence of utrophin
leads to a profound reduction of β2-syntrophin IR; this is
not a result of the disruption of the DPC, since the other
syntrophin isoforms remain unchanged, and since dystro-
brevin staining is enhanced. Therefore, in a DPC contain-
ing only low levels of dystrobrevin, β2-syntrophin appears
to depend on utrophin for association with the DPC. (3)
The loss of utrophin is compensated by the upregulation of
Dp71 and increased staining for β-dystroglycan and β-
dystrobrevin; the resulting DPC is molecularly distinct
from that formed in wild-type mice, but its polarized
distribution in the basal membrane is fully retained.
Our Western blot analysis demonstrates that only the
expression of Dp71 is upregulated in utrophin0/0 mice,
whereas the total protein levels of dystrobrevin and
syntrophins remain largely unchanged, in spite of the
prominent changes in immunoreactivity observed.
Although immunoblot analysis of the entire kidney lacks
spatial selectivity, this observation points to the existence
of an intracellular pool of DPC proteins, independent of
the membrane-associated complex in epithelial cells. The
absence of utrophin might merely change the affinity of
DPC proteins for the complex, thereby shifting the
equilibrium between the DPC and the intracellular pool.
Apparently, the “unused” β2-syntrophin is not degraded,
since this protein is present at comparable levels in wild-
type and utrophin0/0 mice.
Role of utrophin and Dp71 for the formation of the
DPC
The classical model of the DPC in muscle cells postulates
that dystrophin or utrophin is essential for the assembly of
the complex, but that these two proteins are, at least in
part, functionally interchangeable (Blake and Martin-
Rendon 2002). This view has mainly been derived from
the analysis of mdx and mdx/utrophin0/0 mice, which
exhibit strongly reduced levels of dystrobrevins and
syntrophins in the sarcolemma and the NMJ, and from
the demonstration that the retention of dystrophin in
utrophin0/0 mice is sufficient to prevent any deleterious
effects on other DPC proteins (Blake and Martin-Rendon
2002). On the other hand, ablation of a DPC component
such as α-dystrobrevin affects neither dystrophin nor
utrophin, whereas the syntrophins are concomitantly
reduced (Grady et al. 2000). However, ablation of α1-
syntrophin leads to the loss of utrophin at the NMJ,
whereas β1-syntrophin in the sarcolemma and β2-
syntrophin in the NMJ are significantly upregulated
(Adams et al. 2000). The role of syntrophins has further
been examined in polarized epithelial cells in vitro,
demonstrating the essential role of a highly conserved C-
terminal domain for utrophin binding and membrane
targeting (Kachinsky et al. 1999).
In non-muscle cells, the situation is more complex, and
no clear rules have yet emerged. Loh et al. (2000) have
demonstrated that the absence of all dystrophin isoforms in
mdx3Cv mice has no effect on the distribution of DPC
proteins, except that β2-syntrophin is profoundly reduced
in glomeruli and cortical renal tubules. Furthermore,
inactivation of the β-dystrobrevin gene results in a
profound loss of Dp71 and syntrophins, whereas α-
dystrobrevin and utrophin are not altered (Loh et al. 2001).
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Loh et al. (2001) have concluded that β-dystrobrevin
represents a key organizer of the DPC in kidney.
All told, these results indicate that Dp71 and possibly
other dystrophin isoforms, together with α-dystrobrevin
and β-dystrobrevin, have different roles in muscle and
non-muscle tissues with respect to the assembly of the
DPC. It is not established, however, whether this disparity
is attributable to functional differences between the
isoforms, to differences in the molecular composition of
the DPC (for instance, dystroglycan is less abundant in
kidney than in muscle), or to potential redundancies with
other DPC proteins. Our findings in double-mutant mice
indicate that the DPC is disrupted in the absence of both
dystrophin and utrophin. The implications may be that the
mild changes seen in utrophin0/0 mice are attributable to
the presence of Dp71ΔC in the cortex and to the
upregulation of Dp71 in the medulla. Furthermore, these
results show that β-dystrobrevin, in spite of its homology
with dystrophin and utrophin, cannot form a DPC without
one of these partners. Recently, we have shown that both
utrophin and Dp71 play an essential role for assembly of
the DPC also in the cerebrospinal fluid- and blood brain
barriers (Haenggi et al. 2004).
Functional consequences
Utrophin0/0/mdx3Cv double-mutant mice do not exhibit a
devastating pathology in non-muscle tissues (Rafael et al.
1999). The DPC does not appear essential for normal
embryogenesis and development of the kidney or
presumably for its basic function in laboratory animals.
This conclusion does not exclude impaired function under
specific conditions and/or the activation of compensatory
mechanisms to maintain the function of tubular epithelial
cells. Indeed, Loh et al. (2001) have shown that the
glucose/creatine ratio in urine samples from female β-
dystrobrevin-deficient females mice is increased. Since the
glucose transporter protein 1 is localized in the basolateral
membrane of the epithelium of the renal collecting duct
(Farrell et al. 1992), the DPC may contribute to the
anchoring of this transporter to the membrane of collecting
ducts and possibly to the polarized distribution of a vast
array of membrane proteins. In addition, the molecular
heterogeneity of the DPC along the main segments of the
nephron strongly suggests a functional specialization.
Since syntrophins have the potential to bind to various
proteins containing a PDZ-domain (Peters et al. 1997a;
Albrecht and Froehner 2002), the DPC may mediate
specialized signaling functions in kidney epithelial cells.
One might therefore expect alterations in signal transduc-
tion in utrophin0/0/mdx3Cv mice.
Conclusions
The DPC has been localized to the basal membranes of the
epithelial cells of the nephron, and its composition appears
to differ specifically with respect to the various tubular
segments. In the absence of utrophin, the DPC changes its
composition and associates with Dp71, which seems to
replace utrophin at the inner side of the cell membrane.
Upon ablation of not only Dp71, but also all C-terminal
dystrophin isoforms in addition to utrophin, the DPC
disintegrates completely. The double-knockout mice
studied display a fragile phenotype resulting in death
after 3–4 weeks postpartum. Our new findings suggest that
these animals, in addition to muscle disturbances, also
suffer from impaired kidney function.
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